Treatment of cutaneous leishmaniasis with nitric-oxide donor

Lancet

Volumn 351, Issue 9110, 1998, Pages 1176-1177

  Lopez Jaramillo P ^a   Ruano, C ^a   Rivera, J ^a   Teran E ^a   Salazar Irigoyen, R ^a   Esplugues, J V ^a   Moncada, S ^a  

^a UNIVERSIDAD CENTRAL DEL ECUADOR   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; ECUADOR; HUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TOPICAL DRUG ADMINISTRATION;

EID: 0032542898     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79119-4     Document Type: Article

References (4)

1. 1 MacMicking J, Xie Q-W, Nathan C. Nitric oxide and macrophage function. Ann Rev Immunol 1997; 15: 323-50.
2. 2 Arevalo J, Inga R, Lopez M. Polymerase chain reaction. Detection of Leishmania braziliensis. In: Persing DH, Penover FC, Smith TF, White TJ, eds. Diagnostic molecular microbiology: principles and applications. Washington: American Society of Microbiology, 1993: 456-61.
3. 3 Moncada S, Radomski MW, Palmer RMJ. Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol 1988; 37: 2495-501.
4. 4 Yamasaki K, Edington HDJ, McClosky C, et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest (in press).